Cargando…
Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma
We highlighted in this current paper similar prolonged respiratory presentation with COVID-19 pneumonia in four severely immunocompromised patients currently being treated with anti-CD20 monoclonal antibodies (mAbs), such as ocrelizumab and rituximab, for multiple sclerosis or rheumatoid polyarthrit...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675708/ https://www.ncbi.nlm.nih.gov/pubmed/38005897 http://dx.doi.org/10.3390/v15112220 |
_version_ | 1785141128577679360 |
---|---|
author | Da Silva, Léa Klopfenstein, Timothée Gendrin, Vincent Clouet, Julien Toko, Lynda Richier, Quentin Leriche, Thomas Nicolas, Raoul Queijo, Alexis Sreiri, Nour Lacombe, Karine Zayet, Souheil |
author_facet | Da Silva, Léa Klopfenstein, Timothée Gendrin, Vincent Clouet, Julien Toko, Lynda Richier, Quentin Leriche, Thomas Nicolas, Raoul Queijo, Alexis Sreiri, Nour Lacombe, Karine Zayet, Souheil |
author_sort | Da Silva, Léa |
collection | PubMed |
description | We highlighted in this current paper similar prolonged respiratory presentation with COVID-19 pneumonia in four severely immunocompromised patients currently being treated with anti-CD20 monoclonal antibodies (mAbs), such as ocrelizumab and rituximab, for multiple sclerosis or rheumatoid polyarthritis. Real-time reverse transcription-polymerase chain reaction on a nasopharyngeal swab specimen was negative in all patients. SARS-CoV-2 infection was confirmed from bronchoalveolar lavage fluid. A high titer of post-vaccine COVID-19 convalescent plasma was administered with complete recovery in all patients. |
format | Online Article Text |
id | pubmed-10675708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106757082023-11-07 Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma Da Silva, Léa Klopfenstein, Timothée Gendrin, Vincent Clouet, Julien Toko, Lynda Richier, Quentin Leriche, Thomas Nicolas, Raoul Queijo, Alexis Sreiri, Nour Lacombe, Karine Zayet, Souheil Viruses Case Report We highlighted in this current paper similar prolonged respiratory presentation with COVID-19 pneumonia in four severely immunocompromised patients currently being treated with anti-CD20 monoclonal antibodies (mAbs), such as ocrelizumab and rituximab, for multiple sclerosis or rheumatoid polyarthritis. Real-time reverse transcription-polymerase chain reaction on a nasopharyngeal swab specimen was negative in all patients. SARS-CoV-2 infection was confirmed from bronchoalveolar lavage fluid. A high titer of post-vaccine COVID-19 convalescent plasma was administered with complete recovery in all patients. MDPI 2023-11-07 /pmc/articles/PMC10675708/ /pubmed/38005897 http://dx.doi.org/10.3390/v15112220 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Da Silva, Léa Klopfenstein, Timothée Gendrin, Vincent Clouet, Julien Toko, Lynda Richier, Quentin Leriche, Thomas Nicolas, Raoul Queijo, Alexis Sreiri, Nour Lacombe, Karine Zayet, Souheil Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma |
title | Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma |
title_full | Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma |
title_fullStr | Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma |
title_full_unstemmed | Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma |
title_short | Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma |
title_sort | prolonged sars-cov-2 infection in patients receiving anti-cd20 monoclonal antibodies: a diagnostic challenged by negative nasopharyngeal rt-pcr and successful treatment with covid-19 high-titer convalescent plasma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675708/ https://www.ncbi.nlm.nih.gov/pubmed/38005897 http://dx.doi.org/10.3390/v15112220 |
work_keys_str_mv | AT dasilvalea prolongedsarscov2infectioninpatientsreceivinganticd20monoclonalantibodiesadiagnosticchallengedbynegativenasopharyngealrtpcrandsuccessfultreatmentwithcovid19hightiterconvalescentplasma AT klopfensteintimothee prolongedsarscov2infectioninpatientsreceivinganticd20monoclonalantibodiesadiagnosticchallengedbynegativenasopharyngealrtpcrandsuccessfultreatmentwithcovid19hightiterconvalescentplasma AT gendrinvincent prolongedsarscov2infectioninpatientsreceivinganticd20monoclonalantibodiesadiagnosticchallengedbynegativenasopharyngealrtpcrandsuccessfultreatmentwithcovid19hightiterconvalescentplasma AT clouetjulien prolongedsarscov2infectioninpatientsreceivinganticd20monoclonalantibodiesadiagnosticchallengedbynegativenasopharyngealrtpcrandsuccessfultreatmentwithcovid19hightiterconvalescentplasma AT tokolynda prolongedsarscov2infectioninpatientsreceivinganticd20monoclonalantibodiesadiagnosticchallengedbynegativenasopharyngealrtpcrandsuccessfultreatmentwithcovid19hightiterconvalescentplasma AT richierquentin prolongedsarscov2infectioninpatientsreceivinganticd20monoclonalantibodiesadiagnosticchallengedbynegativenasopharyngealrtpcrandsuccessfultreatmentwithcovid19hightiterconvalescentplasma AT lerichethomas prolongedsarscov2infectioninpatientsreceivinganticd20monoclonalantibodiesadiagnosticchallengedbynegativenasopharyngealrtpcrandsuccessfultreatmentwithcovid19hightiterconvalescentplasma AT nicolasraoul prolongedsarscov2infectioninpatientsreceivinganticd20monoclonalantibodiesadiagnosticchallengedbynegativenasopharyngealrtpcrandsuccessfultreatmentwithcovid19hightiterconvalescentplasma AT queijoalexis prolongedsarscov2infectioninpatientsreceivinganticd20monoclonalantibodiesadiagnosticchallengedbynegativenasopharyngealrtpcrandsuccessfultreatmentwithcovid19hightiterconvalescentplasma AT sreirinour prolongedsarscov2infectioninpatientsreceivinganticd20monoclonalantibodiesadiagnosticchallengedbynegativenasopharyngealrtpcrandsuccessfultreatmentwithcovid19hightiterconvalescentplasma AT lacombekarine prolongedsarscov2infectioninpatientsreceivinganticd20monoclonalantibodiesadiagnosticchallengedbynegativenasopharyngealrtpcrandsuccessfultreatmentwithcovid19hightiterconvalescentplasma AT zayetsouheil prolongedsarscov2infectioninpatientsreceivinganticd20monoclonalantibodiesadiagnosticchallengedbynegativenasopharyngealrtpcrandsuccessfultreatmentwithcovid19hightiterconvalescentplasma |